Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VALEANT PHARMACEUTICALS INTL INC T.VRX

Healthcare Drug Manufacturers - Specialty & Generic
"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

Recent & Breaking News (TSX:VRX)

Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes

PR Newswire August 30, 2022

Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction

Canada NewsWire April 13, 2021

Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2020 Results And Provides 2021 Guidance

Canada NewsWire February 24, 2021

Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE(TM) Silicone Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium

Canada NewsWire January 20, 2021

Bausch + Lomb Introduces SimplifEYE(TM) IOL Delivery System For enVista® Toric And Monofocal Preloaded Intraocular Lenses

Canada NewsWire October 27, 2020

Salix To Present Data For Products Across Its Portfolio At The American College Of Gastroenterology 2020 Virtual Annual Meeting

Canada NewsWire October 22, 2020

Bausch Health Licenses Eyenovia's Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12

Canada NewsWire October 12, 2020

Bausch Health Releases Annual Corporate Social Responsibility Report

Canada NewsWire September 23, 2020

Bausch Health To Participate At The 18th Annual Morgan Stanley Global Healthcare Conference

Canada NewsWire September 9, 2020

Bausch Health Resolves Legacy SEC Investigation

Canada NewsWire July 31, 2020

Bausch Health To Participate At Goldman Sachs Annual Global Healthcare Conference

PR Newswire May 21, 2020

Bausch Health Announces 2020 Annual Meeting Of Shareholder Results

Canada NewsWire April 29, 2020

Bausch Health Announces It Is Seeking A Refinancing Amendment To Its Existing Credit Agreement And Conditional Redemption Of Existing Senior Secured Notes

Canada NewsWire February 19, 2020

Ortho Dermatologics Opens 2020 Aspire Higher Scholarship Program

Canada NewsWire February 3, 2020

Ortho Dermatologics Announces 2019 Aspire Higher Scholarship Recipients

Canada NewsWire October 10, 2019

Bausch Health Companies Inc. Will Release Second-Quarter 2019 Financial Results On August 6

Canada NewsWire July 8, 2019

Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%

PR Newswire July 9, 2018

Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA™ (lofexidine)

PR Newswire June 26, 2018

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 51job, Inc. - JOBS

Canada NewsWire June 19, 2018

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Valeant Pharmaceuticals International, Inc. (VRX)

PR Newswire June 19, 2018